Aristotle University Of Thessaloniki (AUTH)
Μελέτη της έκφρασης βιοδεικτών των καρκινικών βλαστοκυττάρων σε λευκοπλακία-δυσπλασία και καρκίνωμα από πλακώδη κύτταρα του βλεννογόνου του στόματος
Abstract
dc:descriptionIntroduction: Cancer stem cells (CSCs) are responsible for initiating the process of carcinogenesis by enabling the self renewal and self proliferation of the cancer cells. Detecting CSCs in tissue samples and the peripheral blood is of immense importance, especially at the early stages of the disease, in order to prevent the local infiltration, the metastasis and the cancer remission. The identification of CSCs’ specific biomarkers is challenging since it requires the identification of specific molecular targets, which ideally should express exclusively or at least mostly in CSCs. The aim of our study is the detection of OCT3-4, SOX 2 and CD147 through immunohistochemistry and qPCR in paraffin embedded samples. Materials & Methods: The study focuses on the expression of the respective genes of CD147 (Custom CD147 Eurofins MWG, Qiagen, Hilden, Germany) , SOX-2 (Qiagen QuantiTect Primer Assay (200) Hs_QSOX2_1_SG QuantiTect Primer Assay, Qiagen, Hilden, Germany) and OCT3/4 (Custom OCT3/4 Eurofins MWG, Qiagen, Hilden, Germany) through qPCR, through the Qiagen protocol in paraffin embedded samples of 12 cases of mildly and non dysplastic leukoplakia and 19 cases of poorly and moderately differentiated oral squamous cell carcinoma. The average expression of the genes under investigation was normalized, compared to the average expression of β actin. In particular, ΔCt was calculated (Ctmean of OCT3/4, SOX-2 and CD147 minus Ctmean of β actin). Statistical analysis was performed through SPSS 2017 Independent Paired T-test and the significance level was set at 0.05 (p=0,05). The study focuses on the detection of the immunohistochemical pattern of expression of CSCs protein-biomarkers CD147 (sc-21746, Santa Cruz Biotechnology, Dallas, Texas, USA), SOX-2 (sc-365823, Santa Cruz Biotechnology, Dallas, Texas, USA) and OCT3/4 (sc-5279, Santa Cruz Biotechnology, Dallas, Texas, USA), through the Dako Envision system, in paraffin embedded samples of 21 cases of oral squamous cell carcinomas (OSCC) and 30 cases of potentially malignant lesions (Leukoplakia, OL), compared to normal oral epithelium. The samples were retrieved from the archives of the Department of Oral Medicine/Pathology, School of Dentistry, Aristotle University of Thessaloniki, Greece during the period 2009-2019. The samples are evaluated through a scale of 1 to 3 which is described as follows: 1: Presence of positive cells in one third of the epithelium, 2: Presence of positive cells in two thirds of the epithelium, 3: Presence of positive cells throughout the epithelium. The biomarkers OCT3-4 and SOX 2 were further evaluated through a scale 1 to 2 which is described as follows: 1: Weak staining, 2: Strong staining. Statistical analysis was performed through SPSS 2017 Pearson Chi-square and the significance level was set at 0.05 (p=0,05). The samples were retrieved from the archives of the Department of Oral Medicine/Pathology, School of Dentistry, Aristotle University of Thessaloniki, the Department of Oral and Maxillofacial Surgery of the Hospital Papanikolaou and the Department of Oral and Maxillofacial Surgery of the Clinic Agios Loukas during the period 2009-2019. All of the experiments took place in the Department of Oral Medicine/Pathology, School of Dentistry and the School of Pharmacology. Results: The nuclear and membranous staining of OCT3/4 was noticed in a limited number of OSCC cases. The nuclear staining of SOX2 was noticed in the majority of the samples, mostly in the basal and parabasal layers of the epithelium. The membranous staining of CD147 was noticed in the majority of the samples, mostly in the basal layer of the epithelium. SOX2 was expressed significantly more in the OSCC group than in the OL group (p-value=0,007) and the normal oral epithelium group (p-value =0.065), in the well differentiated OSCC group than in the mildly dysplastic and non-dysplastic OL group (p-value =0.035), in the poorly and moderately differentiated OSCC group than in the mildly dysplastic and non-dysplastic OL group (p-value =0.003), and in the well differentiated OSCC group than in the normal oral epithelium (p-value =0.048). CD147 was expressed significantly more in the severe and moderately dysplastic OL group than in the mildly dysplastic and non-dysplastic OL group (p-value=0,008), in the well differentiated OSCC group than in the mildly dysplastic and non-dysplastic OL group (p-value =0.058), in the mildly dysplastic and non-dysplastic OL group than in the normal oral epithelium (p-value =0.012), and the well differentiated OSCC group than in the normal oral epithelium (p-value =0.048). However, the expression of OCT3/4 was not statistically significantly altered among the OSCC group, the OL group and normal oral epithelium. All the samples were positive, regarding the gene expression, in the qPCR although no statistically significant correlations were established. Discussion: The characteristic expression of OCT3/4, SOX2 and CD147 in oral potentially malignant and OSCCs lesions suggests the presence of CSCs and their possible implication in oral tumorigenesis even in the states of potentially malignant lesions (leukoplakia). The clinical application of OCT3-4, SOX 2 and CD147 as prognostic factors requires the experimental evaluation in larger number of samples.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Zisis, Vasileios
- Ζήσης, Βασίλειος
Subjects
dc:subject × 19- EMMPRIN/CD147
- Sox2
- OCT3/4
- Λευκοπλακία στόματος
- Καρκίνος στόματος
- Καρκινικά βλαστικά κύτταρα
- Oral leukoplakia
- Oral cancer
- Cancer stem cells
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Οδοντιατρική, Γναθοπροσωπική χειρουργική και Στοματολογία
- Επιστήμες Υγείας
- Επαγγέλματα υγείας
- Clinical Medicine
- Medical and Health Sciences
- Dentistry, Oral Surgery and Medicine
- Health Sciences
- Health Professions
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/52992